These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 25249029)

  • 21. The strategic relevance of manufacturing technology: An overall quality concept to promote innovation preventing drug shortage.
    Panzitta M; Ponti M; Bruno G; Cois G; D'Arpino A; Minghetti P; Mendicino FR; Perioli L; Ricci M
    Int J Pharm; 2017 Jan; 516(1-2):144-157. PubMed ID: 27838294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
    Rose K
    Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmaceuticals for developing countries: an interface of science, technology, and public policy.
    Simon HJ
    Pharos Alpha Omega Alpha Honor Med Soc; 1981; 44(2):9-15. PubMed ID: 12085902
    [No Abstract]   [Full Text] [Related]  

  • 24. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug shortages in the United States: a critical evaluation of root causes and the need for action.
    Gupta DK; Huang SM
    Clin Pharmacol Ther; 2013 Feb; 93(2):133-5. PubMed ID: 23337520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of the health economic impact of medical nutrition in the Netherlands.
    Freijer K; Nuijten MJ
    Eur J Clin Nutr; 2010 Oct; 64(10):1229-34. PubMed ID: 20717125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alcohol research and the alcoholic beverage industry: issues, concerns and conflicts of interest.
    Babor TF
    Addiction; 2009 Feb; 104 Suppl 1():34-47. PubMed ID: 19133913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Future European health care: cost containment, health care reform and scientific progress in drug research.
    Emilien G
    Int J Health Plann Manage; 1997; 12(2):81-101. PubMed ID: 10173136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is multi-level marketing of nutrition supplements a legal and an ethical practice?
    Cardenas D; Fuchs-Tarlovsky V
    Clin Nutr ESPEN; 2018 Jun; 25():133-138. PubMed ID: 29779808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feeding the preterm infant: opportunities and challenges of bringing science to the bedside.
    Neu J; Bradley CL; Ding ZY; Tucker HN; Berseth CL
    J Pediatr; 2013 Mar; 162(3 Suppl):S101-6. PubMed ID: 23445840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Best Pharmaceuticals for Children Act of 2002: the rise of the voluntary incentive structure and congressional refusal to require pediatric testing.
    Breslow LH
    Harvard J Legis; 2003; 40(1):133-93. PubMed ID: 16594116
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Health and nutrition claims made on food: what future?].
    Laplace JP
    Bull Acad Natl Med; 2006 Nov; 190(8):1663-80; discussion 1680-2. PubMed ID: 17650751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developing a pharmaceutical purchasing strategy.
    Hynniman CE
    Hosp Formul; 1992 Sep; 27(9):918-20, 925-7. PubMed ID: 10171225
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Re-engineering drug discovery and development.
    FitzGerald GA
    LDI Issue Brief; 2011 Oct; 17(2):1-4. PubMed ID: 22049582
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of regulatory science on global public health.
    Patel M; Miller MA
    Kaohsiung J Med Sci; 2012 Jul; 28(7 Suppl):S5-9. PubMed ID: 22871603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gazing into the crystal ball: future considerations for ensuring sustained growth of the functional food and nutraceutical marketplace.
    Marinangeli CP; Jones PJ
    Nutr Res Rev; 2013 Jun; 26(1):12-21. PubMed ID: 23561318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmaceutical supply chain in China: current issues and implications for health system reform.
    Yu X; Li C; Shi Y; Yu M
    Health Policy; 2010 Sep; 97(1):8-15. PubMed ID: 20307912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pediatric research: coming of age in the new millennium.
    Milne CP
    Am J Ther; 1999 Sep; 6(5):263-82. PubMed ID: 11329108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaceuticals and medical devices: business practices.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.